Hexagon Capital Partners LLC Aileron Therapeutics Inc Call Options Transaction History

Hexagon Capital Partners LLC

  • $508 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding ALRN

# of Institutions
1
Shares Held
213
Call Options Held
0
Put Options Held
0
View Full List

About AILERON THERAPEUTICS INC

ALRN Quotes by TradingView
  • Ticker ALRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,823,600
  • Market Cap $203M
  • Description
  • Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advan...
More about ALRN
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email